Q
Q Holdings
Advanced cellular therapeutics for incurable CNS diseases, focusing on glial cell-based treatments
About Q Holdings
Q Therapeutics is pioneering the development of human cell-based therapies aimed at treating debilitating and currently incurable diseases of the central nervous system (CNS), including the brain and spinal cord. The company’s innovative approach centers on glial cells, which are non-neuronal cells in the CNS essential for supporting, repairing, and maintaining normal neuron function and health. Q Therapeutics is currently advancing its therapeutic pipeline with an FDA-approved IND application to proceed with a Phase 1/2a clinical trial for patients with Transverse Myelitis (TM), a severe inflammation of the spinal cord that affects approximately 40,000 people in the United States. TM, similar to Multiple Sclerosis, destroys the myelin sheath surrounding nerve fibers in the spinal cord, leading to compromised muscle control and sensation. Q Therapeutics operates in the biopharmaceutical market, targeting healthcare providers and patients suffering from CNS diseases. The company’s business model involves conducting clinical trials to validate the efficacy and safety of its therapies, followed by seeking regulatory approvals and commercializing the treatments. Revenue generation is expected through the sale of approved therapies and potential partnerships or licensing agreements with larger pharmaceutical companies.
Source: Dealroom company dataNews
Open roles
Q Holdings in the Salt Lake City ecosystem
The Q Holdings office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Signal Peak Ventures
vSpring Capital
Salt Lake Life Science Angels (SLLSA)
University of Utah Endowment
EPIC Ventures- TCToucan Capital
Q management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Q Holdings on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Q Holdings on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


